Journal article
Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: A systematic review and meta-analysis
Journal of the American Oil Chemists Society, Vol.99(Suppl. 1)
2022
Abstract
In preclinical AD, the brain gradually becomes insulin resistant causing a cellular energy deficit, which leads to the accumulation of free radicals increasing inflammation and damaging neurons, thus ketone bodies offer an alternative energy source having the potential to supply the insulin-resistant brain with energy and may improve cognition.
Details
- Title
- Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: A systematic review and meta-analysis
- Authors/Creators
- C. Castro (Author/Creator)C. Dias (Author/Creator)H. Sohrabi (Author/Creator)T. Shah (Author/Creator)P. Chatterjee (Author/Creator)H. Hillebrandt (Author/Creator)S. Fuller (Author/Creator)M. Garg (Author/Creator)R. Martins (Author/Creator)
- Publication Details
- Journal of the American Oil Chemists Society, Vol.99(Suppl. 1)
- Publisher
- Wiley
- Identifiers
- 991005541834507891
- Copyright
- © 2019 American Oil Chemists' Society
- Murdoch Affiliation
- Centre for Healthy Ageing
- Language
- English
- Resource Type
- Journal article
- Additional Information
- 2022 AOCS Annual Meeting & Expo, May 1- 4, 2022
Metrics
103 Record Views